In hepatocellular carcinoma (HCC), one of the most significant breakthroughs in exemplifying O-GlcNAcylation–ferroptosis interactions came from Zhou and colleagues’ discovery that TFRC undergoes O-GlcNAcylation, which plays a role in erastin-induced ferroptosis sensitivity [44]. This evidence concerns the gene TFRC and hepatocellular carcinoma.